Skip to Content

Mometasone Topical Dosage

Medically reviewed on September 10, 2018.

Applies to the following strengths: 0.1%

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Dermatitis

Apply a thin layer to the affected area once a day

Comments:
-This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema

Apply a thin layer to the affected area once a day

Comments:
-This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Psoriasis

Apply a thin layer to the affected area once a day

Comments:
-This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Dermatitis

2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day

12 years and older:
Lotion: Apply a thin layer to the affected area once a day

Comments:
-Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
-This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema

2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day

12 years and older:
Lotion: Apply a thin layer to the affected area once a day

Comments:
-Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
-This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Psoriasis

2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day

12 years and older:
Lotion: Apply a thin layer to the affected area once a day

Comments:
-Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
-This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 2 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
-Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Monitoring:
-Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
-Use should be avoided on the face, groin, or axillae.
-Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.
-This medication is to be used as directed by the physician.
-Patients should be advised not to use this medication for any condition other than for which it was prescribed.
-Lotion should not be used in the treatment of diaper dermatitis.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide